Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$370M |
| 2 |
Amazon
AMZN
|
+$349M |
| 3 |
Microsoft
MSFT
|
+$336M |
| 4 |
Meta Platforms (Facebook)
META
|
+$181M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$164M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.07B |
| 2 |
Newmont
NEM
|
+$149M |
| 3 |
Waste Management
WM
|
+$122M |
| 4 |
McDonald's
MCD
|
+$113M |
| 5 |
Eli Lilly
LLY
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.33% |
| 2 | Healthcare | 14.29% |
| 3 | Consumer Discretionary | 13.28% |
| 4 | Communication Services | 11.64% |
| 5 | Industrials | 9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SWN
1126
DELISTED
Southwestern Energy Company
SWN
| $8.41M | 0.01% |
1,482,900
-54,200
| -4% | -$267K |
|
1127
Glaukos
GKOS
$10.9B
| $8.41M | 0.01% |
99,100
+6,600
| +7% | +$542K |
|
|
EXE
1128
Expand Energy Corp
EXE
$21.9B
| $8.41M | 0.01% |
+161,900
| New | +$8.08M |
|
|
APLS
1129
DELISTED
Apellis Pharmaceuticals
APLS
| $8.4M | 0.01% |
132,900
+3,100
| +2% | +$160K |
|
1130
New Jersey Resources
NJR
$5.64B
| $8.4M | 0.01% |
212,200
-7,000
| -3% | -$296K |
|
|
NEWR
1131
DELISTED
New Relic, Inc.
NEWR
| $8.38M | 0.01% |
125,097
+6,600
| +6% | +$425K |
|
1132
Brink's
BCO
$4.71B
| $8.38M | 0.01% |
109,000
-4,000
| -4% | -$311K |
|
1133
Kulicke & Soffa
KLIC
$5.19B
| $8.37M | 0.01% |
136,800
-4,900
| -3% | -$264K |
|
1134
Southwest Gas
SWX
$6.71B
| $8.35M | 0.01% |
126,100
-3,000
| -2% | -$205K |
|
|
SAFM
1135
DELISTED
Sanderson Farms Inc
SAFM
| $8.33M | 0.01% |
44,300
-1,400
| -3% | -$236K |
|
1136
Sabre
SABR
$900M
| $8.29M | 0.01% |
664,500
-60,400
| -8% | -$849K |
|
1137
Spire
SR
$4.9B
| $8.28M | 0.01% |
114,550
-3,400
| -3% | -$253K |
|
1138
Rogers Corp
ROG
$2.55B
| $8.27M | 0.01% |
41,200
-1,500
| -4% | -$287K |
|
1139
Ambarella
AMBA
$3.6B
| $8.27M | 0.01% |
77,533
-1,600
| -2% | -$158K |
|
1140
Maravai LifeSciences
MRVI
$849M
| $8.24M | 0.01% |
+197,500
| New | +$7.65M |
|
|
RETA
1141
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $8.24M | 0.01% |
58,200
+2,200
| +4% | +$248K |
|
|
MZTI
1142
The Marzetti Company
MZTI
$3.18B
| $8.23M | 0.01% |
42,526
-1,500
| -3% | -$282K |
|
|
JBGS
1143
JBG SMITH
JBGS
$672M
| $8.23M | 0.01% |
261,058
-11,500
| -4% | -$375K |
|
|
ARNC
1144
DELISTED
Arconic Corporation
ARNC
| $8.2M | 0.01% |
230,300
+5,900
| +3% | +$195K |
|
1145
AXIS Capital
AXS
$7.38B
| $8.2M | 0.01% |
167,300
-25,300
| -13% | -$1.34M |
|
1146
Mercury Systems
MRCY
$6.67B
| $8.2M | 0.01% |
123,700
-4,300
| -3% | -$297K |
|
1147
Magnite
MGNI
$3.55B
| $8.19M | 0.01% |
242,000
-1,000
| -0.4% | -$33.9K |
|
1148
First Hawaiian
FHB
$3.37B
| $8.18M | 0.01% |
288,567
-10,300
| -3% | -$288K |
|
1149
Adaptive Biotechnologies
ADPT
$3.94B
| $8.15M | 0.01% |
199,500
-3,600
| -2% | -$140K |
|
1150
Commercial Metals
CMC
$7.92B
| $8.13M | 0.01% |
264,700
-9,600
| -3% | -$297K |
|
Similar funds
Swiss National Bank's Q2 2021 Portfolio in Review
As of Q2 2021, Swiss National Bank held 2,687 positions worth $162B, up 8.1% from $150B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Swiss National Bank's Q2 2021 filing shows 205 new, 908 increased, 1,482 reduced and 45 closed positions. Its largest new stake was Lyft: 1,044,300 shares worth $63.2M. The largest sale was Alibaba, an estimated $1.07B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q2 2021 buy was Lyft: 1,044,300 shares worth $63.2M.
- Swiss National Bank added most to Apple in Q2 2021, an estimated $370M increase.
- Swiss National Bank's biggest Q2 2021 reduction was Newmont, cutting an estimated $149M.
- Swiss National Bank fully exited Alibaba in Q2 2021, selling an estimated $1.07B.
- Swiss National Bank's ten largest holdings make up 25% of its $162B portfolio in Q2 2021.
- Swiss National Bank opened 205 new positions and closed 45 in Q2 2021.
- Swiss National Bank's portfolio value rose 8.1% quarter-over-quarter to $162B.
Based on Swiss National Bank's 13F filing for Q2 2021, filed 6 Aug 2021.